We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Psychedelics – News and Features

Psychedelic pattern.

Psychedelic Trips From Psilocybin a Result of Disruptions to the Brain Network

In a new study, researchers report that psilocybin, the active compound in magic mushrooms, temporarily scrambles a critical network of brain areas involved in introspective thinking such as daydreaming and remembering.
A macrophage.

Immune Cell Inflammation Responsible for Severe Symptoms in Rare Neurodegenerative Disease

Researchers at The Hospital for Sick Children (SickKids) have found that inflammation in an immune cell may be responsible in part for some severe symptoms in a group of rare genetic conditions called lysosomal storage diseases (LSDs).
Psilocybe maluti growing on cow manure.

Mushroom Enthusiasts Discover Two New Psilocybe Species

Fungi aficionados have reason to rejoice, as two new species of Psilocybe mushrooms – best known for their psychoactive properties – have been discovered in South Africa.
Psychedelic spirals.

Potentially Safer MDMA Variants Identified for Psychotherapeutic Use

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy", to support psychotherapy for mental illnesses such as post-traumatic stress disorder is being discussed worldwide.
A woman holds a white pill to her mouth

Slow-Release Ketamine Pill Reduces Severe Depression Symptoms, Study Finds

Research has found that a new tablet form of ketamine has shown promise in treating severe depression, offering a potential alternative to existing clinic-based treatments that can be expensive and lacking in convenience for some patients.
A person looking at art.

Older Psychedelic Users Report Fewer Depressive Symptoms

Older individuals who self-reported using psychedelics had fewer depressive symptoms and higher cognitive performance, a new study, published in Gerontology and Geriatric Medicine, has found.
Clouds in rainbow colours in the sky.

LSD Tied to Worse Mental Health After Job Loss

Lifetime LSD use is associated with a higher likelihood of severe psychological distress after losing one’s job. The new work used data from the 2008-2019 National Survey on Drug Use and Health on the United States civilian, non-institutionalized population.
A doctor writing on a clipboard next to a 3D model of a human brain and two orange pill bottles.

New Rules for Psychedelic Therapy Programs

Oregon is first in the nation to provide state-regulated access to magic mushrooms; study is first to identify measures for high-quality services.
A person laying down.
Industry Insight

What FDA Approval of MDMA Could Mean for the Future of Psychedelic Therapy

To learn more about the FDA's pending decision on MDMA-assisted therapy for PTSD, Technology Networks interviewed Dr. Sam Clark, CEO of Terran Biosciences, who leads one of the industry’s largest psychedelic development programs.
Two halves of a drug capsule split, with a drug molecule in the middle.

Nanodroplets and Ultrasound Beams Trigger Drug Delivery at Exactly the Right Spot

In preclinical experiments, researchers optimized a targeted drug delivery method where nanocarriers release their cargo at exactly the desired location.